Vident Advisory’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26M | Buy |
332,079
+43,359
| +15% | +$3.39M | 0.29% | 82 |
|
|
2025
Q1 | $20.9M | Sell |
288,720
-6,663
| -2% | -$483K | 0.31% | 73 |
|
|
2024
Q4 | $21.9M | Buy |
295,383
+285,661
| +2,938% | +$21.1M | 0.38% | 57 |
|
|
2024
Q3 | $642K | Sell |
9,722
-1,736
| -15% | -$115K | 0.02% | 811 |
|
|
2024
Q2 | $1.06M | Buy |
11,458
+831
| +8% | +$76.8K | 0.03% | 579 |
|
|
2024
Q1 | $1.02M | Sell |
10,627
-4,494
| -30% | -$429K | 0.02% | 567 |
|
|
2023
Q4 | $1.15M | Buy |
15,121
+20
| +0.1% | +$1.53K | 0.03% | 520 |
|
|
2023
Q3 | $1.05M | Buy |
+15,101
| New | +$1.05M | 0.03% | 493 |
|